These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Autonomic nervous system disturbances in Parkinson's disease]. Bilińska M; Pokryszko A Neurol Neurochir Pol; 1999; 33(1):23-30. PubMed ID: 10399721 [TBL] [Abstract][Full Text] [Related]
9. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624 [TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease]. Doi H; Sakakibara R; Kishi M; Tsuyuzaki Y; Tateno F; Hirai S Rinsho Shinkeigaku; 2013; 53(11):1382-5. PubMed ID: 24291998 [TBL] [Abstract][Full Text] [Related]
11. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism. de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of advanced Parkinson's disease]. Momose Y; Murata M; Kanazawa I Nihon Rinsho; 2000 Oct; 58(10):2061-5. PubMed ID: 11068447 [TBL] [Abstract][Full Text] [Related]
13. The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease. Walker RW; Howells AR; Gray WK Parkinsonism Relat Disord; 2011 Jan; 17(1):27-9. PubMed ID: 21051272 [TBL] [Abstract][Full Text] [Related]
15. A wrinkle in ON-time - A GI structural abnormality confounding levodopa therapy with Duodopa rescue; a case study. Staisch J; Bakis G; Nutt J Parkinsonism Relat Disord; 2018 May; 50():130-131. PubMed ID: 29478835 [No Abstract] [Full Text] [Related]
16. Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients. Sánchez-Castañeda C; Campdelacreu J; Miró J; Juncadella M; Jaumà S; Calopa M Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):250-1. PubMed ID: 19887096 [No Abstract] [Full Text] [Related]
17. Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease. Müller B; Assmus J; Larsen JP; Haugarvoll K; Skeie GO; Tysnes OB; Acta Neurol Scand; 2013 Apr; 127(4):290-4. PubMed ID: 22998158 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease. Uitti RJ; Wharen RE; Turk MF Neurology; 1998 Dec; 51(6):1755-7. PubMed ID: 9855542 [TBL] [Abstract][Full Text] [Related]
19. Advances in levodopa therapy for Parkinson disease. Gupta S Neurology; 2016 Apr; 86(14 Suppl 1):S1-2. PubMed ID: 27500293 [No Abstract] [Full Text] [Related]
20. Parkinson's disease: recent advances in therapy. Jankovic J South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683 [No Abstract] [Full Text] [Related] [Next] [New Search]